Sathvik Sagi
@idsvs37.bsky.social
📣 New from #JACCP: This paper highlights the critical need for more HIV-trained pharmacists to meet ongoing gaps in care and support growing opportunities in HIV prevention, treatment, and care 📈🧑⚕️💊 #IDSky accpjournals.onlinelibrary.wiley.com/doi/10.1002/...
#PITT_ID26
#PITT_ID26
Need for More HIV‐Trained Pharmacists due to Unmet Needs and Expanding Opportunities: An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy
According to the Centers for Disease Control and Prevention, 1.2 million people are living with human immunodeficiency virus (HIV) in the United States, and an estimated 32 000 new HIV infections are....
accpjournals.onlinelibrary.wiley.com
January 31, 2026 at 6:32 PM
📣 New from #JACCP: This paper highlights the critical need for more HIV-trained pharmacists to meet ongoing gaps in care and support growing opportunities in HIV prevention, treatment, and care 📈🧑⚕️💊 #IDSky accpjournals.onlinelibrary.wiley.com/doi/10.1002/...
#PITT_ID26
#PITT_ID26
Novavax signs licensing agreement with Pfizer for vaccine development.
Novavax signed a licensing deal giving Pfizer access to its vaccine technology to boost immune responses for up to two infectious diseases, sending Novavax shares up nearly 7%.
Novavax signed a licensing deal giving Pfizer access to its vaccine technology to boost immune responses for up to two infectious diseases, sending Novavax shares up nearly 7%.
Novavax signs licensing agreement with Pfizer for vaccine development
Novavax said on Tuesday it signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses to vaccines for use in up to two infectious diseases, and the smaller co...
www.reuters.com
January 25, 2026 at 1:13 AM
"Almost 30 million Americans are walking around saying, ‘I’m allergic to penicillin,’ and they really are not,” says Bruce Jones, PharmD, BCPS, infectious diseases clinical pharmacy specialist. www.sjchs.org/resource-hub...
January 25, 2026 at 1:11 AM